文献速递细胞病理与分子病理神经与头颈病理

牺牲性细胞学涂片锚定多重PCR融合检测的诊断价值

Diagnostic utility of anchored multiplex polymerase chain reaction-based fusion assay on sacrificed cytology slides.
PubMed 文献 · Cancer Cytopathol · 2026-01-01

本研究评估了在牺牲性细胞学涂片上进行锚定多重PCR(AMP)RNA融合检测的临床效用。在807例细胞学标本中,14例使用牺牲性直接涂片,全部获得足够核酸,9例(64%)检出基因融合,支持腺样囊性癌、黏液表皮样癌、多形性腺瘤等肿瘤的明确诊断。

要点

  • 融合检出率64%(9/14),涵盖MYB::NFIB、CRTC1::MAML2等。
  • 融合结果对唾液腺和软组织肿瘤的明确诊断有重要价值。

核心结论

  • 基于AMP的RNA融合检测在牺牲性细胞学涂片上可行、可靠且具有诊断影响力。

研究设计与样本

  • 评估临床验证的锚定多重PCR(AMP)RNA融合检测在数字化、刮取和牺牲性细胞学涂片上的效用。

主要发现

  • 研究期间共8706例融合检测,807例(9.3%)应用于细胞学标本,其中14例(1.7%)使用牺牲性直接涂片。
  • 所有病例均获得足够核酸。
  • 64%(9/14)检出基因融合,包括MYB::NFIB、ACTB::PLAG1、NCALD::PLAG1、CRTC1::MAML2、COL1A1::PDGFB、COL1A2::USP6和FGFR1::NOL4。
  • 融合结果使腺样囊性癌、黏液表皮样癌、多形性腺瘤、结节性筋膜炎和隆突性皮肤纤维肉瘤得到明确诊断。

临床怎么用

  • 在细胞学标本有限或无法获取组织块时,可考虑对牺牲性涂片进行RNA融合检测以辅助肿瘤分类。

局限性

  • 研究仅纳入14例牺牲性涂片,样本量小。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Gene fusion testing, essential for the diagnosis and classification of many salivary gland and soft tissue neoplasms, is typically performed on formalin-fixed paraffin-embedded material, which may be limited or unavailable in cytology specimens. Although cytology smears have been validated for single-gene and DNA-based assays, evidence supporting routine diagnostic use of RNA-based next-generation sequencing fusion testing on smears remains limited. METHODS: The authors evaluated the clinical utility of a clinically validated anchored multiplex polymerase chain reaction (adenosine monophosphate)-based RNA fusion assay performed on digitized, scraped, and sacrificed cytology smears. Alcohol-fixed Papanicolaou-stained and air-dried modified Giemsa-stained smears meeting predefined cellularity thresholds were digitally archived, manually scraped, and processed for RNA extraction. Fusion testing targeted solid tumor-associated genes, and sequencing was performed on an Illumina platform. RESULTS: Of 8706 fusion assays performed during the study period, 807 (9.3%) were applied to cytology specimens, including 14 cases (1.7%) using sacrificed direct smears. Adequate nucleic acid was obtained in all cases. Gene fusions were detected in 64% (9/14), including MYB::NFIB, ACTB::PLAG1, NCALD::PLAG1, CRTC1::MAML2, COL1A1::PDGFB, COL1A2::USP6, and FGFR1::NOL4. Fusion results enabled definitive diagnosis for adenoid cystic carcinoma, mucoepidermoid carcinoma, pleomorphic adenoma, nodular fasciitis, and dermatofibrosarcoma protuberans. CONCLUSIONS: Adenosine monophosphate-based RNA fusion testing on sacrificed cytology smears is feasible, reliable, and diagnostically impactful, expanding the role of cytology specimens in definitive tumor classification.

来源:Cancer Cytopathol,查看原文。版权归原作者所有。

引用

  1. Wang CI, Zhang ML, Madrigal E, et al. Diagnostic utility of anchored multiplex polymerase chain reaction-based fusion assay on sacrificed cytology slides. Cancer Cytopathol. 2026. PMID: 42119039. doi:10.1002/cncy.70105

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。